• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道合胞病毒融合活性多核体测定

Respiratory Syncytial Virus Fusion Activity Syncytia Assay.

作者信息

Edmonds Kearstin, Dutch Rebecca

机构信息

Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA.

出版信息

Methods Mol Biol. 2025;2948:73-83. doi: 10.1007/978-1-0716-4666-3_5.

DOI:10.1007/978-1-0716-4666-3_5
PMID:40879902
Abstract

The methods detailed here measure the membrane fusion activity of viral fusion proteins and are optimized for the respiratory syncytial virus (RSV). RSV utilizes a class I fusion protein (F) to facilitate fusion between a viral and cellular membrane to allow viral entry into host cells. This process is carried out with the assistance of the glycoprotein (G), which attaches to the host-cell surface, allowing F to interact with the target cell. The F protein then undergoes conformational changes, which drive membrane fusion, thus creating a path for viral entry. The fusogenic activity of viral fusion proteins can be quantified by observing and measuring syncytia formation via wide-field microscopy. Syncytia are multinucleated cell masses formed by cell-cell membrane fusion, which in this case are driven by viral fusion proteins expressed on the host-cell surface.

摘要

此处详述的方法用于测量病毒融合蛋白的膜融合活性,并且针对呼吸道合胞病毒(RSV)进行了优化。RSV利用I类融合蛋白(F)促进病毒膜与细胞膜之间的融合,以使病毒进入宿主细胞。此过程在糖蛋白(G)的协助下进行,糖蛋白附着于宿主细胞表面,使F能够与靶细胞相互作用。然后F蛋白发生构象变化,驱动膜融合,从而为病毒进入创造一条途径。病毒融合蛋白的融合活性可以通过宽场显微镜观察和测量多核巨细胞形成来定量。多核巨细胞是由细胞-细胞膜融合形成的多核细胞团,在这种情况下是由宿主细胞表面表达的病毒融合蛋白驱动的。

相似文献

1
Respiratory Syncytial Virus Fusion Activity Syncytia Assay.呼吸道合胞病毒融合活性多核体测定
Methods Mol Biol. 2025;2948:73-83. doi: 10.1007/978-1-0716-4666-3_5.
2
Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein.诃子酸和石榴皮苷均通过多靶点作用于糖蛋白和融合蛋白来抑制呼吸道合胞病毒的进入。
J Virol. 2024 Dec 17;98(12):e0153624. doi: 10.1128/jvi.01536-24. Epub 2024 Nov 7.
3
Examination of respiratory syncytial virus fusion protein proteolytic processing and roles of the P27 domain.呼吸道合胞病毒融合蛋白的蛋白水解加工及P27结构域的作用研究
J Virol. 2024 Dec 17;98(12):e0163924. doi: 10.1128/jvi.01639-24. Epub 2024 Nov 7.
4
Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.细胞融合由人巨细胞病毒糖蛋白 B(gB)的融合活性形式诱导,该融合可被针对 gB 外结构域抗原表位 5 的抗体所抑制。
J Virol. 2020 Aug 31;94(18). doi: 10.1128/JVI.01276-20.
5
Hydrophobic residue substitutions enhance the stability and immunogenicity of respiratory syncytial virus fusion protein.疏水残基取代增强呼吸道合胞病毒融合蛋白的稳定性和免疫原性。
J Virol. 2025 Jun 17;99(6):e0008725. doi: 10.1128/jvi.00087-25. Epub 2025 May 28.
6
Structural Basis for Postfusion-Specific Binding to the Respiratory Syncytial Virus F Protein by the Canonical Antigenic Site I Antibody 131-2a.典型抗原位点I抗体131-2a与呼吸道合胞病毒F蛋白融合后特异性结合的结构基础。
ACS Infect Dis. 2025 Aug 8;11(8):2357-2366. doi: 10.1021/acsinfecdis.5c00368. Epub 2025 Jul 22.
7
Lethal model for respiratory syncytial virus infection using C57BL/6 mice.使用C57BL/6小鼠建立呼吸道合胞病毒感染的致死模型。
J Virol. 2024 Dec 17;98(12):e0177224. doi: 10.1128/jvi.01772-24. Epub 2024 Nov 5.
8
Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model.在水疱性口炎病毒(VSV)载体系统中共同表达呼吸道合胞病毒(RSV)融合(F)蛋白和附着糖蛋白(G)可对棉鼠 RSV 感染产生协同作用。
Vaccine. 2021 Nov 16;39(47):6817-6828. doi: 10.1016/j.vaccine.2021.10.042. Epub 2021 Oct 23.
9
Sub-neutralizing levels of antibodies against RSV F protein enhance RSV infection via Fc-FcγR interactions.针对呼吸道合胞病毒(RSV)F蛋白的亚中和水平抗体通过Fc-FcγR相互作用增强RSV感染。
Front Immunol. 2025 Jun 10;16:1594937. doi: 10.3389/fimmu.2025.1594937. eCollection 2025.
10
Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.通过删除和插入大聚合酶蛋白的 mRNA 加帽和甲基转移酶结构域之间的铰链区中的氨基酸,稳定衰减人呼吸道合胞病毒用于活疫苗。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01831-20.

本文引用的文献

1
Respiratory syncytial virus entry mechanism in host cells: A general overview.呼吸道合胞病毒在宿主细胞中的进入机制:概述。
Mol Microbiol. 2023 Sep;120(3):341-350. doi: 10.1111/mmi.15133. Epub 2023 Aug 3.
2
Respiratory Syncytial Virus-Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis.美国婴儿呼吸道合胞病毒相关住院率:系统评价和荟萃分析。
J Infect Dis. 2022 Mar 15;225(6):1100-1111. doi: 10.1093/infdis/jiaa752.
3
IGF1R is an entry receptor for respiratory syncytial virus.IGF1R 是呼吸道合胞病毒的进入受体。
Nature. 2020 Jul;583(7817):615-619. doi: 10.1038/s41586-020-2369-7. Epub 2020 Jun 3.
4
CX3CR1 as a respiratory syncytial virus receptor in pediatric human lung.CX3CR1 作为儿科人肺中的呼吸道合胞病毒受体。
Pediatr Res. 2020 Apr;87(5):862-867. doi: 10.1038/s41390-019-0677-0. Epub 2019 Nov 14.
5
Molecular mechanism of respiratory syncytial virus fusion inhibitors.呼吸道合胞病毒融合抑制剂的分子机制
Nat Chem Biol. 2016 Feb;12(2):87-93. doi: 10.1038/nchembio.1982. Epub 2015 Dec 7.
6
CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.CX3CR1是呼吸道合胞病毒感染人气道上皮细胞的重要表面分子。
J Gen Virol. 2015 Sep;96(9):2543-2556. doi: 10.1099/vir.0.000218. Epub 2015 Jun 25.
7
Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis.鉴定人呼吸道合胞病毒融合蛋白中调节融合活性和发病机制的残基。
J Virol. 2015 Jan;89(1):512-22. doi: 10.1128/JVI.02472-14. Epub 2014 Oct 22.
8
The human metapneumovirus small hydrophobic protein has properties consistent with those of a viroporin and can modulate viral fusogenic activity.人偏肺病毒小疏水蛋白具有与病毒孔蛋白一致的特性,并能调节病毒的融合活性。
J Virol. 2014 Jun;88(11):6423-33. doi: 10.1128/JVI.02848-13. Epub 2014 Mar 26.
9
Structure and function of respiratory syncytial virus surface glycoproteins.呼吸道合胞病毒表面糖蛋白的结构与功能。
Curr Top Microbiol Immunol. 2013;372:83-104. doi: 10.1007/978-3-642-38919-1_4.
10
RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function.RAGE 通过干扰 F 蛋白功能抑制人呼吸道合胞病毒合胞体的形成。
J Gen Virol. 2013 Aug;94(Pt 8):1691-1700. doi: 10.1099/vir.0.049254-0. Epub 2013 Apr 4.